A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic

- Lal, Anoushka P., Foong, Yi Chao, Roos, Izanne, Lechner-Scott, Jeannette, John, Nevin, Soysal, Aysun, D’Amico, Emanuele, Gouider, Riadh, Mrabet, Saloua, Gross-Paju, Katrin, Cárdenas‑Robledo, Simón, Moghadasi, Abdorreza Naser, Sanfilippo, Paul G., Sa, Maria Jose, Gray, Orla, Oh, Jiwon, Reddel, Stephen, Ramanathan, Sudarshini, Al-Harbi, Talal, Altintas, Ayse, Hardy, Todd A., Ozakbas, Serkan, Alroughani, Raed, Spelman, Tim, Kermode, Allan G., Surcinelli, Andrea, Laureys, Guy, Eichau, Sara, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Hodgkinson, Suzanne, Ramo-Tello, Cristina, Maimone, Davide, Rath, Louise, McCombe, Pamela, Spitaleri, Daniele, Sanchez-Menoyo, Jose Luis, Yetkin, Mehmet Fatih, Baghbanian, Seyed Mohammad, Karabudak, Rana, Al-Asmi, Abdullah, Jakob, Gregor Brecl, Khoury, Samia J., Etemadifar, Masoud, Levitz, David, van Pesch, Vincent, Buzzard, Katherine, Taylor, Bruce, Butzkueven, Helmut, Van der Walt, Anneke, Fabis-Pedrini, Marzena, Foschi, Matteo, Habek, Mario, Kalincik, Tomas

Association of Latitude and Exposure to Ultraviolet B Radiation With Severity of Multiple Sclerosis: An International Registry Study

- Vitkova, Marianna, Diouf, Ibrahima, Onofrj, Marco, Lugaresi, Alessandra, Alroughani, Raed, Prat, Alexandre, Larochelle, Catherine, Girard, Marc, Duquette, Pierre, Terzi, Murat, Boz, Cavit, Grand'Maison, Francois, Malpas, Charles, Sola, Patrizia, Ferraro, D, Grammond, P, Butzkueven, H, Buzzard, K, Skibina, O, Yamout, BI, Karabudak, R, Gerlach, O, Lechner-Scott, Jeannette, Horakova, Dana, Maimone, D, Bergamaschi, R, Van Pesch, V, Iuliano, G, Cartechini, E, José Sà, M, Ampapa, R, Barnett, M, Hughes, SE, Ramo-Tello, CM, Kubala Havrdova, Eva, Hodgkinson, S, Spitaleri, DLA, Petersen, T, Butler, EG, Slee, M, McGuigan, C, McCombe, PA, Granella, F, Cristiano, E, Prevost, J, Patti, Francesco, Taylor, BV, Sãnchez-Menoyo, JL, Laureys, G, Van Hijfte, L, Vucic, S, Macdonell, RA, Gray, O, Olascoaga, J, Deri, N, Fragoso, YD, Ozakbas, Serkan, Shaw, C, Kalincik, T, MSBase Study Group,, Izquierdo, Guillermo, Eichau, Sara, Shaygannejad, Vahid

Clinical and therapeutic predictors of disease outcomes in AQP4-IgG + neuromyelitis optica spectrum disorder

- Kunchok, Amy, Malpas, Charles, Ozakbas, Serkan, Olascoaga, Javier, Simo, Magdolna, Granella, Franco, Patti, Francesco, McCombe, Pamela, Csepany, Tundle, Singhal, Bhim, Bergamaschi, Roberto, Fragoso, Yara, Nytrova, Petra, Al-Harbi, Talal, Turkoglu, Recai, Lechner-Scott, Jeannette, Laureys, Guy, Oreja-Guevara, Celia, Pucci, Eugenio, Sola, Patrizia, Ferraro, Diana, Altintas, Ayse, Soysala, Aysun, Havrdova, Eva Kubala, Vucic, Steve, Grand'Maison, Francois, Izquierdo, Guillermo, Eichau, Sara, Lugaresi, Alessandra, Onofrj, Marco, Trojano, Maria, Marriott, Mark, Butzkueven, Helmut, Kister, Ilya, Alroughani, Raed, Kalincik, Tomas, Terzi, Murat, Yamout, Bassem, Hor, Jyh Yung, Karabudak, Rana, Boz, Cavit

Comparative effectiveness in multiple sclerosis: A methodological comparison

- Roos, Izanne, Diouf, Ibrahima, Onofrj, Marco, Lugaresi, Alessandra, Alroughani, Raed, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Terzi, Murat, Boz, Cavit, Grand'Maison, Francois, Sola, Patrizia, Sharmin, Sifat, Ferraro, Diana, Grammond, P, Turkoglu, R, Buzzard, K, Skibina, O, Yamou, B, Altintas, A, Gerlach, O, van Pesch, V, Blanco, Y, Horakova, Dana, Maimone, D, Lechner-Scott, Jeannette, Bergamaschi, R, Karabudak, R, McGuigan, C, Cartechini, E, Barnett, M, Hughes, S, Sa, MJ, Solaro, C, Havrdova, Eva Kubala, Ramo-Tello, C, Hodgkinson, S, Spitaleri, D, Soysal, A, Petersen, T, Granella, F, de Gans, K, McCombe, P, Ampapa, R, Van Wijmeersch, B, Patti, Francesco, van der Walt, A, Butzkueven, H, Prevost, J, Sanchez-Menoyo, JL, Laureys, G, Gouider, R, Castillo-Triviño, T, Gray, O, Aguera-Morales, E, Al-Asmi, A, Shaygannejad, Vahid, Shaw, C, Deri, N, Al-Harbi, T, Fragoso, Y, Csepany, T, Sempere, AP, Trevino-Frenk, I, Schepel, J, Moore, F, Malpas, C, Ozakbas, Serkan, Kalincik, T, Izquierdo, Guillermo, Eichau, Sara

Comparative effectiveness of dimethyl fumarate versus non-specific immunosuppressants: Real-world evidence from MSBase

- Spelman, Tim, Eichau, Sara, Grammond, Pierre, Lechner-Scott, Jeanette, Gray, Orla, Amato, Maria Pia, Laureys, Guy, Shaygannejad, Vahid, Hyde, Robert, Wang, Haijue, Bozin, Ivan, Belviso, Nicholas, Alroughani, Raed, Quan, Chao, Zeng, Feng, van der Walt, Anneke, Butzkueven, Helmut, MSBase Study Group,, Ozakbas, Serkan, Khoury, Samia J, Patti, Francesco, Havrdova, Eva Kubala, Boz, Cavit, Terzi, Murat, Kuhle, Jens

Comparison Between Dimethyl Fumarate, Fingolimod, and Ocrelizumab After Natalizumab Cessation

- Zhu, Chao, Kalincik, Tomas, Patti, Francesco, Grand'Maison, Francois, Hodgkinson, Suzanne, Grammond, Pierre, Lechner-Scott, Jeannette, Butler, Ernest, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Macdonell, Richard A. L., Horakova, Dana, Weinstock-Guttman, B, Ozakbas, S, Slee, M, Sa, MJ, Van Pesch, V, Barnett, M, Van Wijmeersch, B, Gerlach, O, Prevost, J, Terzi, M, Zhou, Zhen, Boz, C, Laureys, G, Van Hijfte, L, Kermode, AG, Garber, J, Yamout, B, Khoury, SJ, Merlo, D, Monif, M, Jokubaitis, V, Buzzard, Katherine, van der Walt, A, Butzkueven, H, MSBase, SG, Skibina, Olga, Alroughani, Raed, Izquierdo, Guillermo, Eichau, Sara, Kuhle, Jens

Confirmed disability progression as a marker of permanent disability in multiple sclerosis

- Sharmin, Sifat, Bovis, Francesca, Duquette, Pierre, Onofrj, Marco, Lugaresi, Alessandra, Grand'Maison, Francois, Grammond, Pierre, Sola, Patrizia, Ferraro, Diana, Terzi, Murat, Gerlach, Oliver, Alroughani, Raed, Malpas, Charles, Boz, C, Shaygannejad, V, van Pesch, V, Cartechini, E, Kappos, L, Lechner-Scott, Jeanette, Bergamaschi, R, Turkoglu, R, Solaro, C, Iuliano, G, Horakova, Dana, Granella, F, Van Wijmeersch, B, Spitaleri, D, Slee, M, McCombe, P, Prevost, J, Ampapa, R, Ozakbas, S, Sanchez-Menoyo, JL, Soysal, A, Havrdova, Eva Kubala, Vucic, S, Petersen, T, de Gans, K, Butler, E, Hodgkinson, S, Sidhom, Y, Gouider, R, Cristiano, E, Castillo-Trivino, T, Saladino, ML, Izquierdo, Guillermo, Barnett, M, Moore, F, Rozsa, C, Yamout, B, Skibina, O, van der Walt, A, Buzzard, K, Gray, O, Hughes, S, Sempere, AP, Eichau, Sara, Singhal, B, Fragoso, Y, Shaw, C, Kermode, A, Taylor, B, Simo, M, Shuey, N, Al-Harbi, T, Macdonell, R, Dominguez, JA, Trojano, Maria, Csepany, T, Sirbu, CA, Sormani, MP, Butzkueven, H, Kalincik, T, Prat, Alexandre, Girard, Marc

Delay from treatment start to full effect of immunotherapies for multiple sclerosis

- Roos, Izanne, Leray, Emmanuelle, Eichau, Sara, Onofrj, Marco, Lugaresi, Alessandra, Prat, Alexandre, Girard, Marc, Grammond, Pierre, Sola, Patrizia, Ferraro, Diana, Ozakbas, Serkan, Bergamaschi, Roberto, Frascoli, Federico, Sá, Maria José, Cartechini, E, Boz, C, Granella, F, Hupperts, R, Terzi, M, Lechner-Scott, Jeannette, Spitaleri, D, Van Pesch, V, Soysal, A, Casey, Romain, Olascoaga, J, Prevost, J, Aguera-Morales, E, Slee, M, Csepany, T, Turkoglu, R, Sidhom, Y, Gouider, R, Van Wijmeersch, B, McCombe, P, Brown, J. William L., Macdonell, R, Coles, A, Malpas, CB, Butzkueven, H, Vukusic, S, Kalincik, T, Horakova, Dana, Havrdova, Eva K., Trojano, Maria, Patti, Francesco, Izquierdo, Guillermo

Determinants of therapeutic lag in multiple sclerosis

- Roos, Izanne, Leray, Emmanuelle, Izquierdo, Guillermo, Eichau, Sara, Edan, Gilles, Prat, Alexandre, Girard, Marco, Duquette, Pierre, Onofrj, Marco, Lugaresi, Alessandra, Grammond, Pierre, Ciron, Jonathon, Frascoli, Federico, Ruet, A, Ozakbas, S, De Seze, J, Louapre, C, Zephir, H, Sá, MJ, Sola, P, Ferraro, D, Labauge, P, Defer, G, Casey, Romain, Bergamaschi, R, Lebrun-Frenay, C, Boz, C, Cartechini, E, Moreau, T, Laplaud, D, Lechner-Scott, Jeanette, Grand’Maison, F, Gerlach, O, Terzi, M, Brown, J. William L., Granella, F, Alroughani, R, Iuliano, G, Van Pesch, V, Van Wijmeersch, B, Spitaleri, DLA, Soysal, A, Berger, E, Prevost, J, Aguera-Morales, E, Horakova, Dana, McCombe, P, Castillo Triviño, T, Clavelou, P, Pelletier, J, Turkoglu, R, Stankoff, B, Gout, O, Thouvenot, E, Heinzlef, O, Sidhom, Y, Havrdova, Eva Kubala, Gouider, R, Csepany, T, Bourre, B, Al Khedr, A, Casez, O, Cabre, P, Montcuquet, A, Wahab, A, Camdessanche, JP, Maurousset, A, Debouverie, Marc, Patry, I, Hankiewicz, K, Pottier, C, Maubeuge, N, Labeyrie, C, Nifle, C, Coles, A, Malpas, CB, Vukusic, S, Butzkueven, H, Trojano, Maria, Kalincik, T, Patti, Francesco

Disability accrual in primary and secondary progressive multiple sclerosis

- Harding-Forrester, Sam, Roos, Izanne, Horakova, Dana, Kubala Havrdova, Eva, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Grand'Maison, Francois, Onofrj, Marco, Lugaresi, Alessandra, Grammond, Pierre, Ozakbas, Serkan, Nguyen, Ai-Lan, Amato, Maria Pia, Gerlach, O, Sola, P, Ferraro, D, Buzzard, K, Skibina, O, Lechner-Scott, Jeannette, Alroughani, R, Boz, C, Van Pesch, V, Malpas, Charles B., Cartechini, E, Terzi, M, Maimone, D, Ramo-Tello, C, Yamout, B, Khoury, SJ, La Spitaleri, D, Sa, MJ, Blanco, Y, Granella, F, Diouf, Ibrahima, Slee, M, Butler, E, Sidhom, Y, Gouider, R, Bergamaschi, R, Karabudak, R, Ampapa, R, Sanchez-Menoyo, JL, Prevost, J, Castillo-Trivino, T, Moradi, Nahid, McCombe, PA, Macdonell, R, Laureys, G, Van Hijfte, L, Oh, J, Altintas, A, de Gans, K, Turkoglu, R, van der Walt, A, Butzkueven, H, Sharmin, Sifat, Vucic, S, Barnett, M, Cristiano, E, Hodgkinson, S, Iuliano, G, Kappos, L, Kuhle, J, Shaygannejad, V, Soysal, A, Weinstock-Guttman, B, Izquierdo, Guillermo, Van Wijmeersch, B, Kalincik, T, Eichau, Sara, Patti, Francesco

Disability outcomes of early cerebellar and brainstem symptoms in multiple sclerosis

- Le, Minh, Malpas, Charles, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Larochelle, Catherine, Alroughani, Raed, Bergamaschi, Roberto, Sola, Patrizia, Ferraro, Diana, Grammond, Pierre, Grand’ Maison, Francois, Sharmin, Sifat, Lechner-Scott, Jeannette, Boz, C, Hupperts, R, Butzkueven, H, Pucci, E, Granella, F, Van Pesch, V, Soysal, A, Yamout, BI, Lechner-Scott, J, Horáková, Dana, Spitaleri, DLA, Ampapa, R, Turkoglu, R, Iuliano, G, Ramo-Tello, C, Sanchez-Menoyo, JL, Sidhom, Y, Gouider, R, Shaygannejad, V, Prevost, J, Havrdova, Eva, Altintas, A, Fragoso, YD, McCombe, PA, Petersen, T, Slee, M, Barnett, MH, Vucic, S, Van Der Walt, A, Kalincik, T, Trojano, Maria, Izquierdo, Guillermo, Eichau, Sara, Ozakbas, Serkan, Lugaresi, Alessandra

Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis

- Roos, Izanne, Malpas, Charles, Eichau, Sara, Edan, Gilles, Prat, Alexandre, Girard, Marc, Ozakbas, Serkan, Grammond, Pierrre, Zephir, Helene, Ciron, Jonathan, Maillart, Elisabeth, Moreau, Thibault, Leray, Emmanuelle, Amato, MP, Labauge, P, Alroughani, R, Buzzard, K, Skibina, O, Terzi, M, Laplaud, DA, Berger, E, Grand'Maison, F, Lebrun-Frenay, C, Casey, Romain, Cartechini, E, Boz, C, Lechner-Scott, Jeanette, Clavelou, P, Stankoff, B, Prevost, J, Kappos, L, Pelletier, J, Shaygannejad, V, Yamout, B, Horakova, Dana, Khoury, SJ, Gerlach, O, Spitaleri, DLA, Van Pesch, V, Gout, O, Turkoglu, R, Heinzlef, O, Thouvenot, E, McCombe, PA, Soysal, A, Havrdova, Eva Kubala, Bourre, B, Slee, M, Castillo-Trivino, T, Bakchine, S, Ampapa, R, Butler, EG, Wahab, A, Macdonell, RA, Aguera-Morales, E, Cabre, P, Debouverie, Marc, Ben, NH, Van der Walt, A, Laureys, G, Van Hijfte, L, Ramo-Tello, CM, Maubeuge, N, Hodgkinson, S, Sanchez-Menoyo, JL, Barnett, MH, Labeyrie, C, Patti, Francesco, Vucic, S, Sidhom, Y, Gouider, R, Csepany, T, Sotoca, J, de Gans, K, Al-Asmi, A, Fragoso, YD, Vukusic, S, Butzkueven, H, De Seze, Jerome, Kalincik, T, Izquierdo, Guillermo

Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis

- Daruwalla, Cyrus, Shaygannejad, Vahid, Eichau, Sara, Girard, Marc, Prat, Alexandre, Duquette, Pierre, Yamout, Bassem, Khoury, Samia J., Sajedi, Seyed Aidin, Turkoglu, Recai, Altintas, Ayse, Skibina, Olga, Ozakbas, Serkan, Buzzard, Katherine, Grammond, P, Karabudak, R, van der Walt, A, Butzkueven, H, Maimone, D, Lechner-Scott, Jeannette, Soysal, A, John, N, Prevost, J, Havrdova, Eva Kubala, Spitaleri, D, Ramo-Tello, C, Gerlach, O, Iuliano, G, Foschi, M, Ampapa, R, van Pesch, V, Barnett, M, Shalaby, N, D'hooghe, M, Horakova, Dana, Kuhle, J, Sa, MJ, Fabis-Pedrini, M, Kermode, A, Mrabet, S, Gouider, R, Hodgkinson, S, Laureys, G, Van Hijfte, L, Macdonell, R, Alroughani, Raed, Oreja-Guevara, C, Cristiano, E, McCombe, P, Sanchez-Menoyo, JL, Singhal, B, Blanco, Y, Hughes, S, Garber, J, Solaro, C, McGuigan, C, Boz, Cavit, Taylor, B, de Gans, K, Habek, M, Al-Asmi, A, Mihaela, S, Castillo Triviño, T, Al-Harbi, T, Rojas, JI, Gray, O, Khurana, D, Patti, Francesco, Van Wijmeersch, B, Grigoriadis, N, Inshasi, J, Oh, J, Aguera-Morales, E, Fragoso, Y, Moore, F, Shaw, C, Baghbanian, SM, Shuey, N, Onofrj, Marco, Willekens, B, Hardy, TA, Decoo, D, Sempere, AP, Field, D, Wynford-Thomas, R, Cunniffe, NG, Roos, I, Malpas, CB, Coles, AJ, Lugaresi, Alessandra, Kalincik, T, Brown, JWL

Effectiveness of multiple disease-modifying therapies in relapsing-remitting multiple sclerosis: causal inference to emulate a multiarm randomised trial

- Diouf, Ibrahima, Malpas, Charles B., Onofrj, Marco, Lugaresi, Alessandra, Alroughani, Raed, Prat, Alexandre, Duquette, Pierre, Terzi, Murat, Boz, Cavit, Grand'Maison, Francois, Sola, Patrizia, Ferraro, Diana, Sharmin, Sifat, Grammond, P, Yamout, B, Altintas, A, Gerlach, O, Lechner-Scott, Jeannette, Bergamaschi, R, Karabudak, R, Iuliano, G, McGuigan, C, Cartechini, E, Roos, Izanne, Hughes, S, Sa, MJ, Solaro, C, Kappos, L, Hodgkinson, S, Slee, M, Granella, F, de Gans, K, McCombe, PA, Ampapa, R, Horakova, Dana, van der Walt, A, Butzkueven, H, Sánchez-Menoyo, JL, Vucic, S, Laureys, G, Sidhom, Y, Gouider, R, Castillo-Trivino, T, Gray, O, Aguera-Morales, E, Kubala Havrdova, Eva, Al-Asmi, A, Shaw, C, Al-Harbi, TM, Csepany, T, Sempere, AP, Treviño Frenk, I, Stuart, EA, Kalincik, T, Patti, Francesco, Shaygannejad, Vahid, Ozakbas, Serkan, Eichau, Sara

Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies

- Li, Ying, Saul, Alice, Eichau, Sara, Onofrj, Marco, Ozakbas, Serkan, Horakova, Dana, Havrdova, Eva Kubala, Grand'Maison, Francois, Alroughani, Raed, Gerlach, Oliver, Amato, Maria Pia, Altintas, Ayse, Taylor, Bruce, Girard, M, Duquette, P, Blanco, Y, Ramo-Tello, C, Laureys, G, Kalincik, T, Khoury, SJ, Shaygannejad, V, Etemadifar, M, Singhal, B, Ponsonby, Anne-Louise, Mrabet, S, Foschi, M, Habek, M, John, N, Hughes, S, McCombe, P, Ampapa, R, van der Walt, A, Butzkueven, H, de Gans, K, Simpson-Yap, Steve, McGuigan, C, Oreja-Guevara, C, Sa, MJ, Petersen, T, Al-Harbi, T, Sempere, AP, Van Wijmeersch, B, Grigoriadis, N, Prevost, J, Gray, O, Blizzard, Leigh, Castillo-Trivino, T, Macdonell, R, Lugaresi, A, Sajedi, SA, van der Mei, I, Broadley, Simon, Lechner-Scott, Jeannette, Karabudak, Rana, Patti, Francesco

Longitudinal machine learning modeling of MS patient trajectories improves predictions of disability progression

- De Brouwer, Edward, Becker, Thijs, Kappos, Ludwig, Sola, Patrizia, Cartechini, Elisabetta, Lechner-Scott, Jeannette, Alroughani, Raed, Gerlach, Oliver, Kalincik, Tomas, Granella, Franco, Grand'Maison, Francois, Bergamaschi, Roberto, Moreau, Yves, José Sá, M, Van Wijmeersch, B, Soysal, A, Sanchez-Menoyo, JL, Solaro, C, Boz, C, Iuliano, G, Buzzard, K, Aguera-Morales, E, Terzi, M, Havrdova, Eva Kubala, Trivio, TC, Spitaleri, D, Van Pesch, V, Shaygannejad, V, Moore, F, Oreja-Guevara, C, Maimone, D, Gouider, R, Csepany, T, Ramo-Tello, C, Trojano, Maria, Peeters, L, Eichau, Sara, Ozakbas, Serkan, Onofrj, Marco, Grammond, Pierre, Kuhle, Jens

Multiple Sclerosis Relapses Following Cessation of Fingolimod

- Malpas, Charles B., Roos, Izanne, Havrdova, Eva Kubala, Izquierdo, Guillermo, Eichau, Sara, Hodgkinson, Suzanne, Grammond, Pierre, Lechner-Scott, Jeannette, Kalincik, Tomas, MSBase Study Group,, Sharmin, Sifat, Buzzard, Katherine, Skibina, Olga, Butzkueven, Helmut, Kappos, Ludwig, Patti, Francesco, Alroughani, Raed, Horakova, Dana

Multiple Sclerosis Severity Score (MSSS) improves the accuracy of individualized prediction in MS

- Kalincik, Tomas, Kister, Ilya, Ozakbas, Serkan, Onofrj, Marco, Lugaresi, Alessandra, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Grammond, Pierre, Sola, Patrizia, Ferraro, Diana, Alroughani, Raed, Bacon, Tamar E., Terzi, Murat, Boz, C, Grand'Maison, F, Bergamaschi, R, Gerlach, O, Sa, MJ, Kappos, L, Cartechini, E, Lechner-Scott, Jeannette, van Pesch, V, Malpas, Charles B., Shaygannejad, V, Granella, F, Spitaleri, D, Iuliano, G, Maimone, D, Prevost, J, Soysal, A, Turkoglu, R, Ampapa, R, Butzkueven, H, Sharmin, Sifat, Cutter, G, for MSBase Study Group,, Horakova, Dana, Kubala-Havrdova, Eva, Patti, Francesco, Izquierdo, Guillermo, Eichau, Sara

No evidence for association between rs10191329 severity locus and longitudinal disease severity in 1813 relapse-onset multiple sclerosis patients from the MSBase registry

- Campagna, Maria Pia, Havrdova, Eva Kubala, van der Walt, Anneke, Butzkueven, Helmut, Jokubaitis, Vilija G., Horakova, Dana, Izquierdo, Guillermo, Matesanz, Fuencisla, Eichau, Sara, Lechner-Scott, Jeanette, Taylor, Bruce Multiple sclerosis, disease severity, genetics., Garcia-Sanchez, Maria-Isabel, Alcina, Antonio

Not all roads lead to the immune system: the genetic basis of multiple sclerosis severity

- Jokubaitis, Vilija G., Campagna, Maria Pia, Lea, Rodney, Kilpatrick, Trevor J., Kalincik, Tomas, De Jager, Philip L., Beecham, Ashley, McCauley, Jacob L., Taylor, Bruce V., Vucic, Steve, Laverick, Louise, Vodehnalova, Karolina, Ibrahim, Omar, García-Sanchéz, Maria-Isabel, Alcina, A, van der Walt, A, Havrdova, EK, Izquierdo, G, Patsopoulos, N, Horakova, D, Butzkueven, H, Stankovich, Jim, Kleinova, Pavlina, Matesanz, Fuencisla, Hui, Daniel, Eichau, Sara, Slee, Mark, Lechner-Scott, Jeannette